Bionical Emas

Bionical Emas is a global Contract Research Organization (CRO) combining Clinical Development, Clinical Trial Supply (CTS) and Early Access Programs (EAP) bringing life-changing medicines to patients around the world. Our unique integrated business model, with its range of services and capabilities, benefits many of the world's leading pharma and biotech companies. This distinctive offering enables us to maximize access and evidence generation at every stage of the drug development pathway. We have extensive experience across all phases of clinical research, with a rich history in rare diseases, oncology, and infectious diseases.